Early pregnancy Vitamin D status and risk of preeclampsia

Journal of Clinical Investigation

Volumn 126, Issue 12, 2016, Pages 4702-4715

  Mirzakhani, Hooman ^a   Litonjua, Augusto A ^a,b   McElrath, Thomas F ^c   O'Connor, George ^d   Lee Parritz, Aviva ^e   Iverson, Ronald ^e   MacOnes, George ^f   Strunk, Robert C ^g   Bacharier, Leonard B ^g   Zeiger, Robert ^h   Hollis, Bruce W ⁱ   Handy, Diane E ^c   Sharma, Amitabh ^a   Laranjo, Nancy ^a   Carey, Vincent ^a   Qiu, Weilliang ^a   Santolini, Marc ^a,j   Liu, Shikang ^j   Chhabra, Divya ^k   Enquobahrie, Daniel A ^l   Williams, Michelle A ^m   Loscalzo, Joseph ^c   Weiss, Scott T ^a   more..

^a LABORATORY FOR MOLECULAR MEDICINE   (United States)

^b Pulmonary and Critical Care Medicine   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY   (United States)

^f Division of Maternal Fetal Medicine   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h KAISER PERMANENTE   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j NORTHEASTERN UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l UNIVERSITY OF WASHINGTON   (United States)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; MULTIVITAMIN; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THIRD TRIMESTER PREGNANCY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIETARY SUPPLEMENT; MULTICENTER STUDY; PRE-ECLAMPSIA; PREGNANCY;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; RISK FACTORS; VITAMIN D;

EID: 85002566143     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI89031     Document Type: Article

References (57)

1. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21(5):521-526.
2. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71(Suppl 1):S18-S25.
3. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169.
4. Tabesh M, Salehi-Abargouei A, Tabesh M, Esmaillzadeh A. Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(8):3165-3173.
5. Hyppönen E, et al. Vitamin D and pre-eclampsia: original data, systematic review and meta-analy-sis. Ann Nutr Metab. 2013;63(4):331-340.
6. Wei SQ, Qi HP, Luo ZC, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26(9):889-899.
7. Pérez-López FR, et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2015;103(5):1278-1288.e4.
8. Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int. 2013;92(2):128-139.
9. Allen RE, Rogozinska E, Cleverly K, Aquilina J, Thangaratinam S. Abnormal blood biomarkers in early pregnancy are associated with preeclamp-sia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;182:194-201.
10. Hossein-nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS ONE. 2013;8(3):e58725.
11. Enquobahrie DA, Williams MA, Qiu C, Sis-covick DS, Sorensen TK. Global maternal early pregnancy peripheral blood mRNA and miRNA expression profiles according to plasma 25-hydroxyvitamin D concentrations. J Matern Fetal Neonatal Med. 2011;24(8):1002-1012.
12. Rajakumar A, et al. Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta. 2011;32(1):70-78.
13. Sun CJ, Zhang L, Zhang WY. Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers. J Perinat Med. 2009;37(6):609-616.
14. Dahlstrøm B, Esbensen Y, Vollan H, Oian P, Bukholm G. Genome profiles in maternal blood during early onset preeclampsia and towards term. J Perinat Med. 2010;38(6):601-608.
15. Chaiworapongsa T, et al. Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa. J Perinat Med. 2013;41(5):485-504.
16. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL. The human disease network. Proc Natl Acad Sci USA. 2007;104(21):8685-8690.
17. Menche J, et al. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347(6224):1257601.
18. Asemi Z, Esmaillzadeh A. The effect of multi mineral-vitamin D supplementation on pregnancy outcomes in pregnant women at risk for pre-eclampsia. Int J Prev Med. 2015;6:62.
19. Sablok A, et al. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin Endocrinol (Oxf). 2015;83(4):536-541.
20. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517-3522.
21. Wei SQ, et al. Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG. 2012;119(7):832-839.
22. Achkar M, et al. Vitamin D status in early pregnancy and risk of preeclampsia. Am J Obstet Gyne-col. 2015;212(4):511.e1-511.e7.
23. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011;26(10):2341-2357.
24. Litonjua AA, et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: The VDAART Randomized Clinical Trial. JAMA. 2016;315(4):362-370.
25. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-1594.
26. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in pre-eclampsia. J Immunol. 1999;163(6):3491-3495.
27. Makris A, Xu B, Yu B, Thornton C, Hennessy A. Pla-cental deficiency of interleukin-10 (IL-10) in pre-eclampsia and its relationship to an IL10 promoter polymorphism. Placenta. 2006;27(4-5):445-451.
28. Barrera D, Díaz L, Noyola-Martínez N, Halhali A. Vitamin D and inflammatory cytokines in healthy and preeclamptic pregnancies. Nutrients. 2015;7(8):6465-6490.
29. Kalkunte S, Nevers T, Norris WE, Sharma S. Vascular IL-10: a protective role in preeclampsia. J Reprod Immunol. 2011;88(2):165-169.
30. Lai Z, Kalkunte S, Sharma S. A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension. 2011;57(3):505-514.
31. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534-543.
32. Laresgoiti-Servitje E, Gómez-López N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16(5):510-524.
33. Goldman-Wohl D, Yagel S. Regulation of tro-phoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol. 2002; 187(1-2):233-238.
34. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970-975.
35. Kanasaki K, Kalluri R. The biology of preeclamp-sia. Kidney Int. 2009;76(8):831-837.
36. Rabaglino MB, Post Uiterweer ED, Jeyabalan A, Hogge WA, Conrad KP. Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Hypertension. 2015;65(2):421-429.
37. Shin JS, Choi MY, Longtine MS, Nelson DM. Vitamin D effects on pregnancy and the placenta. Placenta. 2010;31(12):1027-1034.
38. Chan SY, et al. Vitamin D promotes human extra-villous trophoblast invasion in vitro. Placenta. 2015;36(4):403-409.
39. De-Regil LM, Palacios C, Lombardo LK, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016;(1):CD008873.
40. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 495: Vitamin D: Screening and supplementation during pregnancy. Obstet Gynecol. 2011;118(1):197-198.
41. Appelgren KE, Nietert PJ, Hulsey TC, Hollis BW, Wagner CL. Analyzing adherence to prenatal supplement: does pill count measure up? Int J Endocrinol. 2010;2010:631971.
42. Litonjua AA, et al. The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp Clin Trials. 2014;38(1):37-50.
43. American College of Obstetricians Gynecologists' Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-1131.
44. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immuno-assays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58(3):531-542.
45. Denburg MR, et al. Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: Implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Miner Res. 2016;31(6):1128-1136.
46. Bouillon R. Free or total 25OHD as marker for vitamin D status? J Bone Miner Res. 2016;31(6):1124-1127.
47. Bourgon R, Gentleman R, Huber W. Indepen-dent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci USA. 2010;107(21):9546-9551.
48. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004;573(1-3):83-92.
49. Enquobahrie DA, Qiu C, Muhie SY, Williams M.A. Maternal peripheral blood gene expression in early pregnancy and preeclampsia. Int J Mol Epidemiol Genet. 2011;2(1):78-94.
50. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011;86(1):50-60.
51. Saggese G, Baroncelli GI, Bertelloni S, Cipolloni C. Intact parathyroid hormone levels during pregnancy, in healthy term neonates and in hypo-calcemic preterm infants. Acta Paediatr Scand. 1991;80(1):36-41.
52. Mulligan ML, Felton SK, Riek AE, Bernal-Mizrachi C. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol. 2010;202(5):429.e1-429.e9.
53. Safran M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010;2010:baq020.
54. Pontén F, Schwenk JM, Asplund A, Edqvist PH. The Human Protein Atlas as a proteomic resource for biomarker discovery. J Intern Med. 2011;270(5):428-446.
55. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM. Prioritizing candidate disease genes by network-based boosting of genome-wide associ-ation data. Genome Res. 2011;21(7):1109-1121.
56. Ashburner M, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25-29.
57. Reimand J, Arak T, Vilo J. g:Profiler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res. 2011;39(Web Server issue):W307-W315.